227 related articles for article (PubMed ID: 34129878)
1. Beta2-microglobulin(B2M) in cancer immunotherapies: Biological function, resistance and remedy.
Wang H; Liu B; Wei J
Cancer Lett; 2021 Oct; 517():96-104. PubMed ID: 34129878
[TBL] [Abstract][Full Text] [Related]
2. Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysis.
Guo Y; Xu B; Wu Z; Bo J; Tong C; Chen D; Wang J; Wang H; Wang Y; Han W
Eur J Immunol; 2021 Oct; 51(10):2513-2521. PubMed ID: 34323289
[TBL] [Abstract][Full Text] [Related]
3. Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Haworth KB; Arnold MA; Pierson CR; Leddon JL; Kurmashev DK; Swain HM; Hutzen BJ; Roberts RD; Cripe TP
Pediatr Blood Cancer; 2016 Apr; 63(4):618-26. PubMed ID: 26575538
[TBL] [Abstract][Full Text] [Related]
4. Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Reis B; Attig J; Dziadek S; Graefe N; Heller A; Rieder N; Gomes B
Front Immunol; 2024; 15():1285049. PubMed ID: 38455061
[TBL] [Abstract][Full Text] [Related]
5. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects.
de Vries NL; van de Haar J; Veninga V; Chalabi M; Ijsselsteijn ME; van der Ploeg M; van den Bulk J; Ruano D; van den Berg JG; Haanen JB; Zeverijn LJ; Geurts BS; de Wit GF; Battaglia TW; Gelderblom H; Verheul HMW; Schumacher TN; Wessels LFA; Koning F; de Miranda NFCC; Voest EE
Nature; 2023 Jan; 613(7945):743-750. PubMed ID: 36631610
[TBL] [Abstract][Full Text] [Related]
6. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
[TBL] [Abstract][Full Text] [Related]
7. Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy.
Kagoya Y; Guo T; Yeung B; Saso K; Anczurowski M; Wang CH; Murata K; Sugata K; Saijo H; Matsunaga Y; Ohashi Y; Butler MO; Hirano N
Cancer Immunol Res; 2020 Jul; 8(7):926-936. PubMed ID: 32321775
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules.
Lhotakova K; Grzelak A; Polakova I; Vackova J; Smahel M
Oncol Rep; 2019 Dec; 42(6):2826-2835. PubMed ID: 31638243
[TBL] [Abstract][Full Text] [Related]
9. The immune-related role of beta-2-microglobulin in melanoma.
Wang C; Wang Z; Yao T; Zhou J; Wang Z
Front Oncol; 2022; 12():944722. PubMed ID: 36046045
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies
Pereira C; Gimenez-Xavier P; Pros E; Pajares MJ; Moro M; Gomez A; Navarro A; Condom E; Moran S; Gomez-Lopez G; Graña O; Rubio-Camarillo M; Martinez-Martí A; Yokota J; Carretero J; Galbis JM; Nadal E; Pisano D; Sozzi G; Felip E; Montuenga LM; Roz L; Villanueva A; Sanchez-Cespedes M
Clin Cancer Res; 2017 Jun; 23(12):3203-3213. PubMed ID: 28302866
[No Abstract] [Full Text] [Related]
11. Nonstructural Protein 4 of Porcine Reproductive and Respiratory Syndrome Virus Modulates Cell Surface Swine Leukocyte Antigen Class I Expression by Downregulating β2-Microglobulin Transcription.
Qi P; Liu K; Wei J; Li Y; Li B; Shao D; Wu Z; Shi Y; Tong G; Qiu Y; Ma Z
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003480
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
13. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes.
Castro A; Ozturk K; Pyke RM; Xian S; Zanetti M; Carter H
BMC Med Genomics; 2019 Jul; 12(Suppl 6):107. PubMed ID: 31345234
[TBL] [Abstract][Full Text] [Related]
14. Immune checkpoint blockade resistance-related B2M hotspot mutations in microsatellite-unstable colorectal carcinoma.
Yeon Yeon S; Jung SH; Jo YS; Choi EJ; Kim MS; Chung YJ; Lee SH
Pathol Res Pract; 2019 Jan; 215(1):209-214. PubMed ID: 30503610
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
16. Beta-2 microglobulin knockout K562 cell-based artificial antigen presenting cells for
Zha S; Li Z; Chen C; Du Z; Tay JC; Wang S
Immunotherapy; 2019 Aug; 11(11):967-982. PubMed ID: 31218907
[No Abstract] [Full Text] [Related]
17. A simple method to predict protein-binding from aligned sequences--application to MHC superfamily and beta2-microglobulin.
Duprat E; Lefranc MP; Gascuel O
Bioinformatics; 2006 Feb; 22(4):453-9. PubMed ID: 16352655
[TBL] [Abstract][Full Text] [Related]
18. β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system.
Ardeniz Ö; Unger S; Onay H; Ammann S; Keck C; Cianga C; Gerçeker B; Martin B; Fuchs I; Salzer U; İkincioğulları A; Güloğlu D; Dereli T; Thimme R; Ehl S; Schwarz K; Schmitt-Graeff A; Cianga P; Fisch P; Warnatz K
J Allergy Clin Immunol; 2015 Aug; 136(2):392-401. PubMed ID: 25702838
[TBL] [Abstract][Full Text] [Related]
19. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
Margalit A; Fishman S; Berko D; Engberg J; Gross G
Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Han C; Kwon BS
Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]